K970631 · Odyssey Medical, Inc. · LZU · Apr 23, 1997 · OP
Device Facts
Record ID
K970631
Device Name
PUNCTUAL OCCLUDER
Applicant
Odyssey Medical, Inc.
Product Code
LZU · OP
Decision Date
Apr 23, 1997
Decision
SESE
Submission Type
Traditional
Device Class
Class U
Attributes
Therapeutic
Intended Use
Punctal Occluders are intended for the treatment of “dry eye” conditions through the total occlusion of individual punctal openings.
Device Story
Punctal occluder; small plug-shaped device; inserted into punctal openings to treat dry eye. Material: medical-grade silicone with titanium dioxide colorant. Operation: mechanical occlusion of punctum; fully reversible; non-invasive; no tissue breach required. Used by clinicians in office settings. Benefits: provides relief for dry eye symptoms; avoids permanent surgical methods; allows for easy removal/reversal without tissue damage.
Clinical Evidence
No clinical data provided; substantial equivalence based on design and material comparison to pre-amendment predicate.
{0}
n970631
ODYSSEY
APR 23 1997
# SECTION 5 - 510(K) SUMMARY
Submitted: February 15, 1997
By: Raymond G. Wallace
Trade Name: Punctal Occluder
Common Name: Punctum Plugs
Classification Name: Punctum Plugs (per 21 CFR § 886)
## Summary:
This device, made of medical grade silicone and titanium dioxide as a colorant under current good manufacturing practices, is a small, generally “plug” shaped design. Punctal Occluders are intended for the treatment of “dry eye” conditions through the total occlusion of individual punctal openings.
By material, design and intended use, the Odyssey Punctal Occluder is substantially equivalent to the pre-amendment EV - Freeman Punctum Plug.
Differences between the two devices may be described as follows:
1. The Eagle Vision plug has a slight “taper” which they have patent protection on, however, their pre-amendment device has no such “taper” and is identical to the Odyssey device. The claims made by Eagle Vision in favor of the “tapered shaft” have no known data to support them and no 510(k) to suggest that the design change is significant enough to warrant it.
2. The titanium dioxide present in both devices is used as a colorant. As such, it is Odyssey’s opinion that less titanium dioxide does not hinder the visibility of the device.
Alternative methods are either permanent or difficult to reverse. In contrast, the submitted method is both functionally safe and fully reversible. Unlike some other methods, this device does not require the breach of intact tissue surfaces nor the risk of damaging said surfaces should reversal become desirable.
ODYSSEY Medical, Inc. / 1710 Shelby Oaks Drive, Suite21 / Memphis, TN 38134 / 901-383-7777 / FAX 901-382-2712
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.